BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19289141)

  • 1. Liver cancer mortality among male prison inmates in Texas, 1992-2003.
    Harzke AJ; Baillargeon JG; Goodman KJ; Pruitt SL
    Prev Med; 2009 Jun; 48(6):588-92. PubMed ID: 19289141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV-related mortality among male prison inmates in Texas, 1994-2003.
    Harzke AJ; Baillargeon JG; Kelley MF; Diamond PM; Goodman KJ; Paar DP
    Ann Epidemiol; 2009 Aug; 19(8):582-9. PubMed ID: 19443239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic liver disease mortality among male prison inmates in Texas, 1989-2003.
    Harzke AJ; Baillargeon J; Paar DP; Pulvino J; Murray OJ
    Am J Gastroenterol; 2009 Jun; 104(6):1412-9. PubMed ID: 19491854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leading medical causes of mortality among male prisoners in Texas, 1992--2003.
    Harzke AJ; Baillargeon JG; Kelley MF; Pruitt SL; Pulvino JS; Paar DP
    J Correct Health Care; 2011 Jul; 17(3):241-53. PubMed ID: 21576121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma prevalence and mortality in a male state prison population.
    Baillargeon J; Snyder N; Soloway RD; Paar D; Baillargeon G; Spaulding AC; Pollock BH; Arcari CM; Williams BA; Raimer BG
    Public Health Rep; 2009; 124(1):120-6. PubMed ID: 19413034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The infectious disease profile of Texas prison inmates.
    Baillargeon J; Black SA; Leach CT; Jenson H; Pulvino J; Bradshaw P; Murray O
    Prev Med; 2004 May; 38(5):607-12. PubMed ID: 15066363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system.
    Baillargeon J; Wu H; Kelley MJ; Grady J; Linthicum L; Dunn K
    Public Health; 2003 Jan; 117(1):43-8. PubMed ID: 12802904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disease profile of Texas prison inmates.
    Baillargeon J; Black SA; Pulvino J; Dunn K
    Ann Epidemiol; 2000 Feb; 10(2):74-80. PubMed ID: 10691060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing epidemiology of HIV in the criminal justice system.
    Baillargeon J; Pulvino JS; Leonardson JE; Linthicum LC; Williams B; Penn J; Williams RS; Baillargeon G; Murray OJ
    Int J STD AIDS; 2017 Nov; 28(13):1335-1340. PubMed ID: 28449629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of HIV-related survival among Texas prison inmates.
    Baillargeon J; Borucki M; Williamson J; Dunn K
    AIDS Patient Care STDS; 1999 Jun; 13(6):355-61. PubMed ID: 10842856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prison tobacco control policies and deaths from smoking in United States prisons: population based retrospective analysis.
    Binswanger IA; Carson EA; Krueger PM; Mueller SR; Steiner JF; Sabol WJ
    BMJ; 2014 Aug; 349():g4542. PubMed ID: 25097186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-cause and cause-specific mortality among black and white North Carolina state prisoners, 1995-2005.
    Rosen DL; Wohl DA; Schoenbach VJ
    Ann Epidemiol; 2011 Oct; 21(10):719-26. PubMed ID: 21737304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of chronic medical conditions among inmates in the Texas prison system.
    Harzke AJ; Baillargeon JG; Pruitt SL; Pulvino JS; Paar DP; Kelley MF
    J Urban Health; 2010 May; 87(3):486-503. PubMed ID: 20393884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-cause and cause-specific mortality among men released from state prison, 1980-2005.
    Rosen DL; Schoenbach VJ; Wohl DA
    Am J Public Health; 2008 Dec; 98(12):2278-84. PubMed ID: 18923131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV Seroprevalence among newly incarcerated inmates in the Texas correctional system.
    Wu ZH; Baillargeon J; Grady JJ; Black SA; Dunn K
    Ann Epidemiol; 2001 Jul; 11(5):342-6. PubMed ID: 11399449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prison Population Reductions and COVID-19: A Latent Profile Analysis Synthesizing Recent Evidence From the Texas State Prison System.
    Vest N; Johnson O; Nowotny K; Brinkley-Rubinstein L
    J Urban Health; 2021 Feb; 98(1):53-58. PubMed ID: 33337529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release from prison--a high risk of death for former inmates.
    Binswanger IA; Stern MF; Deyo RA; Heagerty PJ; Cheadle A; Elmore JG; Koepsell TD
    N Engl J Med; 2007 Jan; 356(2):157-65. PubMed ID: 17215533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic predictors of HIV-related survival among Texas prison inmates.
    Baillargeon J; Grady J; Borucki MJ
    AIDS Patient Care STDS; 2000 Apr; 14(4):183-7. PubMed ID: 10806636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Causes and trends of mortality in a Spanish prison (1994-2009)].
    García-Guerrero J; Vera-Remartínez EJ; Planelles Ramos MV
    Rev Esp Salud Publica; 2011 Jun; 85(3):245-55. PubMed ID: 21892549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral prescribing patterns in the Texas prison system.
    Baillargeon J; Borucki MJ; Zepeda S; Jenson HB; Leach CT
    Clin Infect Dis; 2000 Dec; 31(6):1476-81. PubMed ID: 11096015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.